Aurobindo Pharma falls 6% after USFDA classifies inspection as OAI

Aurobindo Pharma has already submitted its initial response to USFDA

from Latest News http://bit.ly/2Jr6W8o
https://ift.tt/eA8V8J http://bit.ly/2SdCH5P

• Tweet
• Share
• Share
• Share
• Share